Balloon battle: which coated catheter wins for tiny heart arteries?
NCT ID NCT04058990
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial tests two types of drug-coated balloon catheters to treat small, newly blocked heart arteries. About 180 adults with stable or unstable angina will be randomly assigned to receive one of the two devices during a standard angioplasty procedure. The goal is to see which balloon better keeps the artery open and reduces the chance of future heart problems.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Paclitaxel-coated balloon catheter
What this could lead to
If successful, this could provide a better treatment option for people with small vessel coronary artery disease, potentially reducing the need for stents or repeat procedures.
What could go wrong
This is a relatively small trial (180 participants) and compares two existing devices, so major breakthroughs are unlikely. There is a risk of heart attack or need for repeat procedures, as with any angioplasty.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Japan Labour Health and Welfare Organization Kanto Rosai Hospital
Kawasaki, Kanagawa, 211-8510, Japan
-
Kokura Memorial Hospital
Kitakyushu, Fukuoka, 802-8555, Japan
-
Kyoto-Katsura Hospital
Kyoto, Kyoto, 615-8256, Japan
-
Miyazaki Medical Association Hospital
Miyazaki, Miyazaki, 880-0834, Japan
-
Osaka Saiseikai Nakatsu Hospital
Kita, Osaka, 530-0012, Japan
-
Saiseikai Yokohama-City Eastern Hospital
Yokohama, Kanagawa, 230-8765, Japan
-
Sakurabashi Watanabe Advanced Healthcare Hospital
Osaka, Osaka, 530-0001, Japan
-
Sapporo Higashi Tokushukai Hospital
Sapporo, Hokkaido, 065-0033, Japan
-
Sendai Kousei Hospital
Sendai, Miyagi, 980-0873, Japan
-
Shonan Kamakura General Hospital
Ōfuna, Kanagawa, 247-8533, Japan
-
Showa Medical University Hospital
Shinagawa-Ku, Tokyo, 142-8666, Japan
-
Teikyo University Hospital
tabashi City, Tokyo, 173-8606, Japan
-
Toho University Ohashi Medical Center
Meguro City, Tokyo, 153-8515, Japan
-
Tokyo Women's Medical University Hospital
Shinjuku-Ku, Tokyo, 162-8666, Japan